Test
AIM ImmunoTech, Inc. operates as a biopharmaceutical company, which engages in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated,...
AIM
post covid therapy treatment
Big Market value potential
About AIM ImmunoTech Inc.
AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, including COVID-19, the disease caused by the SARS-CoV-2 virus.
Based on recent data and the indications , safety data (already used in humans) and a need by various communities such as people afflicted with ME this should be the number one meme stock for getting people help while sticking it to the naked shorts. Insiders buying and with indications and data it should already be there. The market is currently subscribing...
DISCLAIMER
This is in no way, shape or form, fluid and function, an analytical, qualitative or intelligent compte rendu. There is absolutely no financial advice here because the only financial advice I can give is to research, research, and research. The purpose of this analysis is to serve as an example of a small chart analysis.
It looks like the current...
Hello, take a seat and enjoy my basic analysis of AIM. I am not an analyst, of finances or anything else, just a dude saying friendly dude things. I could be the dude that everyone is friends with at the office, or I could be your crazy QAnon neighbour with a Ron Paul sign out front. Please do not trust anything I write without double checking and doing your own...
see easy and self explanatory boxes on chart for Entry, Exit and Stop loss zones. Never chase any stock.
Not for any recommendation, Just an Idea. Like it >> Click 👍/comment, and follow.
Last week closed 3 trades from previous posts ( HX +65% in 83 days; CYRN +29% in 36 days; SPCB +80 in 31 days)
Peaks are getting lower while troughs are getting higher in the duration of 5 days. You won't get a more obvious pennant than this.
Now what makes this pennant bullish ?
Well if we look at the Weekly log scale, we can see a clear case of a cup and handle, and we're almost done with the handle :)
If we look at the same chart, we can see it broke a 5 year long...
JUST GOT POSITIVE EU RECOMMENDATION
$AIM (old $HEB) granted EU Orphan Drug Designation for Rintatolimod for treatment of pancreatic cancer, Hemispherx Biopharma Europe.
Rintatolimod is Ampligen
This is going to trap shorts and when they PR this is going to explode!
www.ema.europa.eu
Pupm&Dump trading strategy idea.
$AIM is rising without clear preconditions today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $2,49;
stop-loss — $2,77;
take-profit — $1,93;
Do not view this idea as a recommendation for trading or...
Guys are waiting for a short on January 5-12, then sell on February 1-25 at 2.14-2.33 and get a profit of 35-55%. If it's not difficult for you to rate my analytics and + REP if not difficult) I am not a professional analyst but I do what I can!
AIM ImmunoTech Announces IRB Approval to Enroll COVID-19 ‘Long Haulers’ in the AMP-511 ME/CFS Clinical Trial of Ampligen.
Many survivors of the first SARS-CoV-1 epidemic in 2003 continued to report classic chronic fatigue-like symptoms after recovering from the acute illness. In fact, approximately 27% of survivors met the CDC criteria for chronic fatigue...
